Oslo University Hospital diversifies its patient offering and scales up the use of Integrum’s OPRA[TM] Implant System
Mölndal, Sweden, September 13[th], 2022 – Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announced that the Oslo University Hospital (Rikshospitalet) will expand its patient offering to include the OPRA[TM] Implant System adapted for artificial thumb replacement surgery. Rikshospitalet has previously performed surgeries using OPRA[TM] Implant System in above-knee patients and is now scaling up the number of surgeries in eligible patients.In April of this year, the Department of Orthopaedics at Rikshospitalet successfully performed its first surgeries using OPRA[TM]